103 related articles for article (PubMed ID: 16307439)
1. Motor evoked potentials in a mouse model of chronic multiple sclerosis.
Amadio S; Pluchino S; Brini E; Morana P; Guerriero R; Martinelli Boneschi F; Comi G; Zaratin P; Muzio V; del Carro U
Muscle Nerve; 2006 Feb; 33(2):265-73. PubMed ID: 16307439
[TBL] [Abstract][Full Text] [Related]
2. Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease.
Mazón Peláez I; Vogler S; Strauss U; Wernhoff P; Pahnke J; Brockmann G; Moch H; Thiesen HJ; Rolfs A; Ibrahim SM
Hum Mol Genet; 2005 Jul; 14(14):1977-89. PubMed ID: 15917267
[TBL] [Abstract][Full Text] [Related]
3. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
4. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Lo AC; Saab CY; Black JA; Waxman SG
J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
9. Evoked potentials (EPs) in experimental allergic encephalomyelitis: a study of EP modifications during the course of a controlled disease.
Onofrj M; Gambi D; Bazzano S; Colamartino P; Fulgente T; Malatesta G; Ferracci F
Electromyogr Clin Neurophysiol; 1992 Mar; 32(3):125-35. PubMed ID: 1555527
[TBL] [Abstract][Full Text] [Related]
10. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
11. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
Onuki M; Ayers MM; Bernard CC; Orian JM
Microsc Res Tech; 2001 Mar; 52(6):731-9. PubMed ID: 11276125
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
Lieu A; Tenorio G; Kerr BJ
J Neuroimmunol; 2013 Mar; 256(1-2):43-8. PubMed ID: 23385082
[TBL] [Abstract][Full Text] [Related]
13. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
[TBL] [Abstract][Full Text] [Related]
14. Restoration of conduction in the spinal roots correlates with clinical recovery from experimental autoimmune encephalomyelitis.
Chalk JB; McCombe PA; Pender MP
Muscle Nerve; 1995 Oct; 18(10):1093-100. PubMed ID: 7659103
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
Parvaneh Tafreshi A
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the clinical scoring and demyelination in central nervous system with total antioxidant capacity of plasma during experimental autoimmune encephalomyelitis development in mice.
Zargari M; Allameh A; Sanati MH; Tiraihi T; Lavasani S; Emadyan O
Neurosci Lett; 2007 Jan; 412(1):24-8. PubMed ID: 17157437
[TBL] [Abstract][Full Text] [Related]
18. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.
Pineda AA; Ogata K; Osoegawa M; Murai H; Shigeto H; Yoshiura T; Tobimatsu S; Kira J
J Neurol Sci; 2007 Apr; 255(1-2):1-6. PubMed ID: 17306302
[TBL] [Abstract][Full Text] [Related]
19. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent.
Recks MS; Addicks K; Kuerten S
Neurosci Lett; 2011 May; 494(3):227-31. PubMed ID: 21406210
[TBL] [Abstract][Full Text] [Related]
20. Differential changes in axonal conduction following CNS demyelination in two mouse models.
Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
